InvestorsHub Logo
icon url

blackhawks

01/16/14 10:17 AM

#92454 RE: JLM27 #92428

The best way by far for a drug company to get paid is through reimbursement from ins/Medicare/Medicaid as opposed to out-of-pocket from the patient.




What I'm saying is that at this point CPT codes are a 'shiny object' distraction. Firstly...successful LymPro patient clinicals, THEN use by drug companies who do not receive reimbursement for patient clinical drug trials for non-life threatening diseases and only then, and only maybe if there are AD treatments, do private practicioners start using the test.

Those are very likely the reasons that there is no acceptable LymPro 'deal' within Gerald's grasp...at this time.

Potential LymPro suitors/JV partners would/have likely beat Gerald severely about the head and shoulders over those exact points.
icon url

blackhawks

01/16/14 10:20 AM

#92457 RE: JLM27 #92428

The best way by far for a drug company to get paid is through reimbursement from ins/Medicare/Medicaid as opposed to out-of-pocket from the patient.




What I'm saying is that at this point CPT codes are a 'shiny object' distraction. Firstly...successful LymPro patient clinicals, THEN use by drug companies who do not receive reimbursement for patient clinical drug trials for non-life threatening diseases and only then, and only maybe if there are AD treatments, do private practicioners start using the test.

Those are very likely the reasons that there is no acceptable LymPro 'deal' within Gerald's grasp...at this time.

Potential LymPro suitors/JV partners would/have likely beat Gerald severely about the head and shoulders over those exact points.